Literature DB >> 26979637

Risk factors and patterns of early recurrence after curative hepatectomy for hepatocellular carcinoma.

Fumitoshi Hirokawa1, Michihiro Hayashi2, Mitsuhiro Asakuma2, Tetsunosuke Shimizu2, Yoshihiro Inoue2, Kazuhisa Uchiyama2.   

Abstract

BACKGROUND: Hepatocellular carcinoma (HCC) often recurs after curative hepatectomy; and early recurrence after hepatectomy (ERAH) is associated with poor prognosis. This study aimed to clarify risk factors and disease patterns for ERAH.
METHODS: We retrospectively analyzed clinicopathological factors of 232 patients who underwent initial curative hepatectomies for HCC between April 2000 and March 2013, and examined associated risk factors and early recurrence patterns by liver function status (as indicated by indocyanine green retention rate at 15 min [ICGR15]).
RESULTS: Patients who experienced recurrence within 6 months after hepatectomy (i.e., ERAH) had significantly shorter survival than those with longer disease-free intervals (P < 0.001). In multivariate analysis, microvascular invasion (mVI; P = 0.034) and ICGR15 ≥ 16% (P = 0.010) were independent risk factors for ERAH. In the ICGR1<16% subgroup, positive L3-AFP (P = 0.04), tumor size ≥ 5 cm (P = 0.011), surgical margin = 0 (P = 0.0103), mVI (P = 0.034), and extrahepatic recurrence were significant predictors of ERAH; in the ICGR15 ≥ 16%, subgroup, multiple tumors (P = 0.046) were identified as a risk factor for ERAH; however, this group did not experience much extrahepatic recurrence.
CONCLUSIONS: ERAH was associated with mVI and ICGR15 ≥ 16%. Recurrence patterns and risk factors vary by liver function status, which should be considered in forming management strategies for early recurrence of HCC after curative hepatectomy.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Early recurrence; Hepatocellular carcinoma; ICGR15; Indocyanine green retention rate at 15 min; Microvascular invasion; Treatment strategy

Mesh:

Substances:

Year:  2015        PMID: 26979637     DOI: 10.1016/j.suronc.2015.12.002

Source DB:  PubMed          Journal:  Surg Oncol        ISSN: 0960-7404            Impact factor:   3.279


  37 in total

1.  Characteristics of Early Recurrence After Curative Liver Resection for Solitary Hepatocellular Carcinoma.

Authors:  Sung-Mi Jung; Jong Man Kim; Gyu-Seong Choi; Choon Hyuck David Kwon; Nam-Joon Yi; Kwang-Woong Lee; Kyung Suk Suh; Jae-Won Joh
Journal:  J Gastrointest Surg       Date:  2018-09-13       Impact factor: 3.452

2.  IVIM improves preoperative assessment of microvascular invasion in HCC.

Authors:  Yi Wei; Zixing Huang; Hehan Tang; Liping Deng; Yuan Yuan; Jiaxing Li; Dongbo Wu; Xiaocheng Wei; Bin Song
Journal:  Eur Radiol       Date:  2019-03-15       Impact factor: 5.315

3.  Actual 10-Year Survivors After Resection of Hepatocellular Carcinoma.

Authors:  Jian Zheng; Deborah Kuk; Mithat Gönen; Vinod P Balachandran; T Peter Kingham; Peter J Allen; Michael I D'Angelica; William R Jarnagin; Ronald P DeMatteo
Journal:  Ann Surg Oncol       Date:  2016-12-05       Impact factor: 5.344

4.  Preoperative Prediction of Microvascular Invasion in Hepatocellular Carcinoma Using Quantitative Image Analysis.

Authors:  Jian Zheng; Jayasree Chakraborty; William C Chapman; Scott Gerst; Mithat Gonen; Linda M Pak; William R Jarnagin; Ronald P DeMatteo; Richard K G Do; Amber L Simpson
Journal:  J Am Coll Surg       Date:  2017-09-21       Impact factor: 6.113

5.  Outcomes and recurrence patterns following curative hepatectomy for hepatocellular carcinoma patients with different China liver cancer staging.

Authors:  Changxian Li; Hongwei Wang; Ruixiang Chen; Hui Zhang; Yonghua Xu; Bin Zhang; Yong Li; Changhe Zhang; Yue Yang; Xuehao Wang; Xiangcheng Li
Journal:  Am J Cancer Res       Date:  2022-02-15       Impact factor: 6.166

6.  Tenofovir Is Superior to Entecavir on Tertiary Prevention for BCLC Stage 0/A Hepatocellular Carcinoma after Curative Resection.

Authors:  Ming-Chao Tsai; Chih-Chi Wang; Wei-Chen Lee; Chih-Che Lin; Kuo-Chin Chang; Chien-Hung Chen; Chao-Hung Hung; Ming-Tsung Lin; Chang-Chun Hsiao; Chao-Long Chen; Rong-Nan Chien; Tsung-Hui Hu
Journal:  Liver Cancer       Date:  2021-09-21       Impact factor: 11.740

7.  Contrast-enhanced ultrasound-based ultrasomics score: a potential biomarker for predicting early recurrence of hepatocellular carcinoma after resection or ablation.

Authors:  Hui Huang; Si-Min Ruan; Meng-Fei Xian; Ming-de Li; Mei-Qing Cheng; Wei Li; Yang Huang; Xiao-Yan Xie; Ming-de Lu; Ming Kuang; Wei Wang; Hang-Tong Hu; Li-Da Chen
Journal:  Br J Radiol       Date:  2021-11-29       Impact factor: 3.039

8.  Pattern of disease recurrence and its implications for postoperative surveillance after curative hepatectomy for hepatocellular carcinoma: experience from a single center.

Authors:  Kit-Fai Lee; Charing C N Chong; Anthony K W Fong; Andrew K Y Fung; Hon-Ting Lok; Yue-Sun Cheung; John Wong; Paul B S Lai
Journal:  Hepatobiliary Surg Nutr       Date:  2018-10       Impact factor: 7.293

9.  Very Early Recurrence After Liver Resection for Intrahepatic Cholangiocarcinoma: Considering Alternative Treatment Approaches.

Authors:  Diamantis I Tsilimigras; Kota Sahara; Lu Wu; Dimitrios Moris; Fabio Bagante; Alfredo Guglielmi; Luca Aldrighetti; Matthew Weiss; Todd W Bauer; Sorin Alexandrescu; George A Poultsides; Shishir K Maithel; Hugo P Marques; Guillaume Martel; Carlo Pulitano; Feng Shen; Olivier Soubrane; B Groot Koerkamp; Amika Moro; Kazunari Sasaki; Federico Aucejo; Xu-Feng Zhang; Ryusei Matsuyama; Itaru Endo; Timothy M Pawlik
Journal:  JAMA Surg       Date:  2020-09-01       Impact factor: 14.766

10.  Change in the Recurrence Pattern and Predictors over Time after Complete Cure of Hepatocellular Carcinoma.

Authors:  Han Ah Lee; Young-Sun Lee; Beom Kyung Kim; Young Kul Jung; Seung Up Kim; Jun Yong Park; Ji Hoon Kim; Hyunggin An; Do Young Kim; Hyung Joon Yim; Sang Hoon Ahn; Jong Eun Yeon; Kwan Soo Byun; Kwang-Hyub Han; Soon Ho Um; Yeon Seok Seo
Journal:  Gut Liver       Date:  2021-05-15       Impact factor: 4.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.